The discussion on this episode of Casual Conversations centers on the safety of drug-to-drug interactions involving cannabis and pharmaceuticals.
Dr. Han shares his journey into cannabis medicine from his background in pharmacy, emphasizing the importance of monitoring interactions through the CYP450 enzyme. The panel further discusses the role and challenges of pharmacists and medical professionals in recommending and managing cannabis treatments. Key points include the therapeutic benefits of cannabis alongside opioids, safety concerns, and the complexities of cannabis as a Schedule I drug.
Dr. Tishler highlights the theoretical and practical aspects of drug interactions, noting how clinical observations often diverge from theoretical risks. Dr. Abodeely adds insights from his surgical practice, emphasizing the importance of coordination with other medical doctors. Dr. Marcu discusses sourcing, labeling, and the importance of reliable cannabis products.
The conversation underlines the need for better education among medical professionals about cannabis and highlights resources provided by the Association of Cannabinoid Specialists.
Featured in this episode are Dr. Jordan Tishler, John Malanca, Dr. Adam Abodeely, Jahan Marcu, PhD, and Minh Han, PharmD.